Mark T Iwicki - Net Worth and Insider Trading
Mark T Iwicki Net Worth
The estimated net worth of Mark T Iwicki is at least $3 Million dollars as of 2024-04-28. Mark T Iwicki is the CHIEF EXECUTIVE OFFICER of Kala Bio Inc and owns about 286,315 shares of Kala Bio Inc (KALA) stock worth over $2 Million. Mark T Iwicki is also the Director of Aimmune Therapeutics Inc and owns about 29,375 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $1 Million. Details can be seen in Mark T Iwicki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark T Iwicki has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).
Transaction Summary of Mark T Iwicki
Mark T Iwicki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark T Iwicki owns 7 companies in total, including Aimmune Therapeutics Inc (AIMT) , Merus NV (MRUS) , and Kala Bio Inc (KALA) among others .
Click here to see the complete history of Mark T Iwicki’s form 4 insider trades.
Insider Ownership Summary of Mark T Iwicki
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AIMT | Aimmune Therapeutics Inc | 2020-10-10 | director |
MRUS | Merus NV | 2021-05-28 | director |
KALA | Kala Bio Inc | 2024-01-04 | director & Chief Executive Officer |
AKRO | Akero Therapeutics Inc | 2022-06-02 | director |
PULM | Pulmatrix Inc | 2015-12-08 | director |
AVTE | Aerovate Therapeutics Inc | 2021-06-29 | director |
THRD | Third Harmonic Bio Inc | 2022-09-14 | director |
Mark T Iwicki Latest Holdings Summary
Mark T Iwicki currently owns a total of 2 stocks. Among these stocks, Mark T Iwicki owns 286,315 shares of Kala Bio Inc (KALA) as of January 4, 2024, with a value of $2 Million and a weighting of 64.03%. Mark T Iwicki also owns 29,375 shares of Aimmune Therapeutics Inc (AIMT) as of February 26, 2018, with a value of $1 Million and a weighting of 35.97%.
Latest Holdings of Mark T Iwicki
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KALA | Kala Bio Inc | 2024-01-04 | 286,315 | 6.30 | 1,803,785 |
AIMT | Aimmune Therapeutics Inc | 2018-02-26 | 29,375 | 34.49 | 1,013,144 |
Holding Weightings of Mark T Iwicki
Mark T Iwicki Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark T Iwicki has made a total of 7 transactions in Kala Bio Inc (KALA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Kala Bio Inc is the sale of 4,539 shares on January 4, 2024, which brought Mark T Iwicki around $30,548.
According to the SEC Form 4 filings, Mark T Iwicki has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 9,375 shares on February 26, 2018, which cost Mark T Iwicki around $300,000.
Insider Trading History of Mark T Iwicki
- 1
Mark T Iwicki Trading Performance
GuruFocus tracks the stock performance after each of Mark T Iwicki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark T Iwicki is -7.63%. GuruFocus also compares Mark T Iwicki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark T Iwicki within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark T Iwicki's insider trading performs compared to the benchmark.
Performance of Mark T Iwicki
Average Return
-31.43%
Outperforming Transactions
0%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 6.26 | -7.63 | -19.26 | -31.43 | -7.58 | 7.25 |
Relative Return to S&P 500(%) | 11.38 | -6.36 | -14.85 | -34.12 | -14.64 | -3.53 |
Mark T Iwicki Ownership Network
Ownership Network List of Mark T Iwicki
Ownership Network Relation of Mark T Iwicki
Mark T Iwicki Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Mark T Iwicki is the director of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Mark T Iwicki Mailing Address
Above is the net worth, insider trading, and ownership report for Mark T Iwicki. You might contact Mark T Iwicki via mailing address: 84 Waterford Drive, Marlborough Ma 01752.